Inflammatory Bowel Disease (IBD)

Every day, millions of people around the world are challenged by debilitating diseases that are the result of an imbalance in the immune system. At Janssen, we are focusing our scientific expertise on restoring immune balance and advancing the discovery and development of new medicines that will redefine the way we approach immune-mediated inflammatory diseases.

We are driven by our commitment to people living with IBD, working side-by-side with healthcare stakeholders, to offer solutions based on trust and transparency.

Our mission is clear, and we will not rest until we achieve a world where immune-mediated inflammatory disease is a thing of the past.

My IBD Journey

My IBD Journey offers guidance on how to plan and manage the range of symptoms you may encounter as an individual living with Inflammatory Bowel Disease (IBD), allowing you to live your life to the fullest.

Find out more

References

[1]

NHS. Amyloidosis. Accessed May 26, 2022.

[2]

McCausland KL, White MK, Guthrie SD, et al. Light chain (AL) amyloidosis: the journey to diagnosis. The Patient-Patient-Centered Outcomes Research. 2018;11(2):207-16.

[3]

Cancer.Net. Amyloidosis: Symptoms and Signs. Accessed May 26, 2022.

[4]

Mayo Clinic. Amyloidosis overview: symptoms and causes. Accessed May 26, 2022.

[5]

National Organization for Rare Disorders. Amyloidosis. Accessed May 26, 2022.

[6]

D'Errico S, Mazzanti A, Baldari B, Maiese A, Frati P, Fineschi V. Sudden death in lambda light chain AL cardiac amyloidosis: a review of literature and update for clinicians and pathologists. Int J Clin Exp Pathol. 2020 Jul 1;13(7):1474-1482. PMID: 32782665; PMCID: PMC7414507.

[7]

Mayo Clinic. Amyloidosis diagnosis and treatment. Accessed August 20, 2020.

[8]

Lousada I, Comenzo RL, Landau H, et al. Light chain amyloidosis: patient experience survey from the Amyloidosis Research Consortium. Advances in Therapy. 2015;32(10):920-928.

[9]

Merlini G, Dispenzieri A, Sanchorawala V, et al. Systematic immunglobulin light chain amyloidosis. Nature Review Disease Primers. 2018;4(1):38.

[10]

Hasib Sidiqi M, Gertz MA. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021. Blood cancer journal. 2021;11(5):1-9.